Exendin-4 Improves Blood Glucose Control in Both Young and Aging Normal Non-Diabetic Mice, Possible Contribution of Beta Cell Independent Effects Aging and Exendin-4 Therapy
2011
Exendin-4 Improves Blood Glucose Control in Mice of Different Ages
Sample size: 12
publication
10 minutes
Evidence: moderate
Author Information
Author(s): Fan Rongrong, Kang Zhanfang, He Lan, Chan Juliana, Xu Gang
Primary Institution: The Chinese University of Hong Kong
Hypothesis
Does aging affect the glucose regulatory effects of exendin-4 in mice?
Conclusion
Exendin-4 treatment improves glucose control in both young and aging mice, independent of beta cell function.
Supporting Evidence
- Exendin-4 improved glycemic control in both young and aging mice.
- The blood glucose lowering effect was independent of beta cell function.
- Insulin sensitivity improved in aging mice but not in young mice.
- Exendin-4 treatment did not significantly change beta cell mass or proliferation.
Takeaway
Exendin-4 helps lower blood sugar in both young and old mice, even though it doesn't increase insulin production.
Methodology
Mice were treated with exendin-4 for 10 days, and blood glucose and body weight were measured, along with OGTT and ITT tests.
Limitations
The study was conducted on mice, and results may not directly translate to humans.
Participant Demographics
C57/DBA mice aged 3 months and 20-22 months.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website